Clinical Trial Update: Efficacy and Safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese Patients With Type 2 Diabetes Mellitus

View source ↗

Summary

This clinical trial entry describes a study evaluating the efficacy and safety of Henagliflozin, Retagliptin, and Metformin Extended-Release Tablets in Chinese …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Henagliflozin (henagliflozin)
• Metformin Extended-Release Tablets (metformin extended-release)
• Retagliptin (Retagliptin)

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: T2DM (Type 2 Diabetes Mellitus) | Status: NOT_YET_RECRUITING